Genfit SA (NASDAQ:GNFT)
| 3.20 Delayed Data As of Nov 29 |  0.00 / 0.00%Today’s Change | 2.89 Today|||52-Week Range 4.75 | -27.09% Year-to-Date |
Latest GNFT News | Press Releases
No recent news for Genfit SA.
Today’s Trading
| Previous close | 3.20 |
| Today’s open | 3.24 |
| Day’s range | 3.20 - 3.24 |
| Volume | 5,600 |
| Average volume (3 months) | 20,003 |
| Market cap | $146.0M |
Data as of 11:13am ET, 11/29/2023
Growth & Valuation
| Earnings growth (last year) | -128.24% |
| Earnings growth (this year) | +78.40% |
| Earnings growth (next 5 years) | +37.40% |
| Revenue growth (last year) | -77.57% |
| P/E ratio | NM |
| Price/Sales | 10.27 |
| Price/Book | 1.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Ecogreen Internation... | 0.00 | 0.00% |
| PDSBPDS Biotechnology Co... | -0.01 | -0.19% |
| ESPREsperion Therapeutic... | +0.10 | +7.52% |
| VRCAVerrica Pharmaceutic... | +0.16 | +4.35% |
Data as of 4:00pm ET, 12/01/2023
Financials
| Last reporting date | October 1, 2020 |
| EPS forecast (this quarter) | -$0.44 |
| Annual revenue (last year) | $21.2M |
| Annual profit (last year) | -$24.9M |
| Net profit margin | -117.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Loos, Hauts-de-france |
Forecasts
Chart unavailable
